Searched for
SWISS DRUGMAKER ROCHE
Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...- Roche ramps up AI computing capacity with Nvidia chip expansionRoche said the additional hardware would speed up work across its research and development operations, including modelling, data analysis...
- Roche to invest $50 billion in US to avoid Trump tariffs, create 12,000 jobsSwiss pharmaceutical giant Roche announced a $50 billion U.S. investment to expand R&D and manufacturing, countering Trump-era tariffs and ...
- Natco to sell rare spinal disease drug Risdiplam for ₹15,900Each bottle of Risdiplam lasts around 12 days and that will take the cost to roughly ₹30,000 per month for the patient. Sources said Roche ...
- Roche considering divesting $1.9 billion cancer data startup: reportRoche had paid $1.9 billion for New-York based Flatiron Health in 2018 to speed its development of cancer medicines and support its efforts...
- Roche says controlling family won't have to make offer to other shareholdersThe pool of family shareholders, who previously owned 45.01% of the voting rights in Roche, were given the exemption by the Swiss takeover ...
- Roche launches lab antigen test to support high-volume COVID-19 testingThe Elecsys SARS-CoV-2 antigen test is an automated laboratory assay intended as an aid in diagnosis of active SARS-CoV-2 infection, Roche ...
- Swiss drugmaker Roche says demand for Covid-19 tests exceeds production"The demand exceeds our production," Christoph Franz was quoted as saying in Saturday's paper. The decision on where tests were shipped to ...
- Roche says prostate cancer drug hit one trial goal, missed anotherSwiss drugmaker Roche said on Friday its experimental medicine ipatasertib hit one goal of a late-stage clinical trial against a small slic...
- Health groups lash out at HC order baning Biocon, Mylan from selling biosimilar breast cancer drugPublic health groups lashed out at High Court order that stopped Biocon, Mylan from selling biosimilar versions of breast cancer drug Herce...
- Biocon launches breast-cancer drug CANMAbPriced at Rs 19,500 per vial, Biocon is expecting to target close to 35,000 patients with this drug.
- IPAB's verdict on Roche's Hepatitis C drug patent may impact MerckThe IPAB revoked Roche's patent for Pegasys on grounds that the process of pegylation did not enhance the efficacy of the drug.
- Cipla’s patent win against Roche boosts hopes of generic drugmakersThe Delhi HC ruling favouring India’s second largest drugmaker Cipla has come as a shot in the arm for other generic makers who are fightin...
- Cipla gets relief as SC rejects Roche pleaThe Supreme Court on Friday rejected Swiss drugmaker Roche’s petition to stop Indian firm Cipla from selling the generic version of its can...
- Swiss drugmaker Roche completes Genentech takeoverSwiss pharmaceutical giant Roche said it has completed its $46.8 billion takeover of California-based biotech firm Genentech.
- Genentech tells shareholders to reject Roche bidGenentech Inc. says its shareholders should reject a hostile buyout bid from Swiss drugmaker Roche.
- No antidote to stop copies of patented drugs: Health minHealth ministry says not equipped with technical expertise to stop domestic pharmaceutical cos from copying patented drugs.
- Dr Reddy's Laboratories wins round 1 of patent warUS court dismisses one of the three patent claims made by Roche for Boniva; DRL still in litigation for two other listed patents.
- Roche buys US firm for $3.4 bnRoche, the world’s biggest maker of cancer drugs, agreed to buy Ventana Medical Systems with an increased offer of $3.4 billion to gain tes...
- Roche files for Avastin to treat breast cancer in EuropeSwiss drugmaker Roche has filed its Avastin drug for use in previously untreated advanced breast cancer in Europe, the company said on Mond...
Load More
